BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8134400)

  • 1. Interplay of positive and negative effectors in function of the C-terminal repeat domain of RNA polymerase II.
    Li Y; Kornberg RD
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2362-6. PubMed ID: 8134400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTD kinase associated with yeast RNA polymerase II initiation factor b.
    Feaver WJ; Gileadi O; Li Y; Kornberg RD
    Cell; 1991 Dec; 67(6):1223-30. PubMed ID: 1836979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphorylation of the C-terminal repeat domain of RNA polymerase II facilitates dissociation of its complex with mediator.
    Søgaard TM; Svejstrup JQ
    J Biol Chem; 2007 May; 282(19):14113-20. PubMed ID: 17376774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transcription factor reveals a functional link between the RNA polymerase II CTD and TFIID.
    Koleske AJ; Buratowski S; Nonet M; Young RA
    Cell; 1992 May; 69(5):883-94. PubMed ID: 1591782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation.
    Baskaran R; Escobar SR; Wang JY
    Cell Growth Differ; 1999 Jun; 10(6):387-96. PubMed ID: 10392900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription.
    Serizawa H; Conaway JW; Conaway RC
    Nature; 1993 May; 363(6427):371-4. PubMed ID: 8497323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-specific requirement of RNA polymerase II CTD phosphorylation.
    Drogat J; Hermand D
    Mol Microbiol; 2012 Jun; 84(6):995-1004. PubMed ID: 22553990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast carboxyl-terminal domain kinase I positively and negatively regulates RNA polymerase II carboxyl-terminal domain phosphorylation.
    Patturajan M; Conrad NK; Bregman DB; Corden JL
    J Biol Chem; 1999 Sep; 274(39):27823-8. PubMed ID: 10488128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Instability Maintains the Repeat Length of the Yeast RNA Polymerase II C-terminal Domain.
    Morrill SA; Exner AE; Babokhov M; Reinfeld BI; Fuchs SM
    J Biol Chem; 2016 May; 291(22):11540-50. PubMed ID: 27026700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of RNA polymerase II elongation efficiency by C-terminal heptapeptide repeat domain kinase I.
    Lee JM; Greenleaf AL
    J Biol Chem; 1997 Apr; 272(17):10990-3. PubMed ID: 9110987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA polymerase II carboxy-terminal domain contributes to the response to multiple acidic activators in vitro.
    Liao SM; Taylor IC; Kingston RE; Young RA
    Genes Dev; 1991 Dec; 5(12B):2431-40. PubMed ID: 1752437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations.
    West ML; Corden JL
    Genetics; 1995 Aug; 140(4):1223-33. PubMed ID: 7498765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA polymerase II phosphorylation: uncoupling from GAL4-VP16 directed open complex formation and transcription in a reconstituted system.
    Jiang Y; Gralla JD
    Nucleic Acids Res; 1994 Nov; 22(23):4958-62. PubMed ID: 7800486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separable functions of the fission yeast Spt5 carboxyl-terminal domain (CTD) in capping enzyme binding and transcription elongation overlap with those of the RNA polymerase II CTD.
    Schneider S; Pei Y; Shuman S; Schwer B
    Mol Cell Biol; 2010 May; 30(10):2353-64. PubMed ID: 20231361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C-terminal domain phosphorylation in RNA polymerase II transcription through the nucleosome.
    Liu YV; Clark DJ; Tchernajenko V; Dahmus ME; Studitsky VM
    Biopolymers; 2003 Apr; 68(4):528-38. PubMed ID: 12666177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II.
    Bourquin JP; Stagljar I; Meier P; Moosmann P; Silke J; Baechi T; Georgiev O; Schaffner W
    Nucleic Acids Res; 1997 Jun; 25(11):2055-61. PubMed ID: 9153302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription.
    Gebara MM; Sayre MH; Corden JL
    J Cell Biochem; 1997 Mar; 64(3):390-402. PubMed ID: 9057097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RNA polymerase II carboxy terminal domain phosphorylation in DNA damage response.
    Jeong SJ; Kim HJ; Yang YJ; Seol JH; Jung BY; Han JW; Lee HW; Cho EJ
    J Microbiol; 2005 Dec; 43(6):516-22. PubMed ID: 16410768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.
    Xiao H; Lis JT; Xiao H; Greenblatt J; Friesen JD
    Nucleic Acids Res; 1994 Jun; 22(11):1966-73. PubMed ID: 8029001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.